MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

MDT

89.25

-0.49%↓

VEEV

279.43

-1.02%↓

A

113.17

-5.79%↓

WBA

11.5

-0.09%↓

HQY

96.22

-1.19%↓

Search

IQVIA Holdings Inc

Cerrado

SectorSanidad

157.94 -1.34

Resumen

Variación precio

24h

Actual

Mínimo

157.52

Máximo

162.06

Métricas clave

By Trading Economics

Ingresos

-188M

249M

Ventas

-129M

3.8B

P/B

Media del Sector

22.407

39.564

BPA

2.7

Margen de beneficios

6.503

Empleados

89,000

EBITDA

-268M

753M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

+8.91% upside

Dividendos

By Dow Jones

Próximas Ganancias

22 jul 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

-7.2B

28B

Apertura anterior

159.28

Cierre anterior

157.94

Noticias sobre sentimiento de mercado

By Acuity

19%

81%

21 / 376 Clasificación en Healthcare

Puntuación técnica

By Trading Central

Confianza

Bullish Evidence

IQVIA Holdings Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

14 jul 2025, 22:07 UTC

Principales Movimientos del Mercado

Trade Desk Rises on S&P 500 Inclusion

14 jul 2025, 17:06 UTC

Principales Movimientos del Mercado

Crypto Assets Rally Ahead of Possible U.S. Legislation

14 jul 2025, 16:47 UTC

Adquisiciones, fusiones, absorciones

NatWest to Sell Stake in Permanent TSB

14 jul 2025, 23:46 UTC

Charlas de Mercado

Nikkei May Rise as Yen Weakens -- Market Talk

14 jul 2025, 23:38 UTC

Charlas de Mercado

Gold Edges Higher Ahead of U.S. CPI Data -- Market Talk

14 jul 2025, 23:37 UTC

Charlas de Mercado

ANZ's Institutional Earnings Likely to Weigh on Outlook -- Market Talk

14 jul 2025, 23:29 UTC

Charlas de Mercado

South32 Bull Eyes Possible Last-Minute Power Deal for Mozal -- Market Talk

14 jul 2025, 23:29 UTC

Charlas de Mercado

Global Energy Roundup: Market Talk

14 jul 2025, 23:02 UTC

Ganancias

China Vanke: Additional Provision for Asset Impairment Also Among Factors Weighing on Results >000002.SZ

14 jul 2025, 23:02 UTC

Ganancias

China Vanke: Weakness in Overall China Real-Estate Sector Weighed on Results >000002.SZ

14 jul 2025, 23:02 UTC

Ganancias

China Vanke 1H Loss Was CNY9.85B >000002.SZ

14 jul 2025, 23:01 UTC

Ganancias

China Vanke Sees 1H Loss CNY10.0B-Loss CNY12.0B >000002.SZ

14 jul 2025, 23:01 UTC

Ganancias

China Vanke Expects 1H Loss to Widen >000002.SZ

14 jul 2025, 20:50 UTC

Charlas de Mercado

Tech, Media & Telecom Roundup: Market Talk

14 jul 2025, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

14 jul 2025, 20:07 UTC

Charlas de Mercado

Cloud Computing Giants Will Be the Winner from Software's Loss -- Market Talk

14 jul 2025, 20:05 UTC

Charlas de Mercado

Adobe and Salesforce May Struggle to Keep Up With AI Agents -- Market Talk

14 jul 2025, 19:11 UTC

Charlas de Mercado

Oil Retreats Despite Trump Threats of Russia Sanctions -- Market Talk

14 jul 2025, 19:09 UTC

Charlas de Mercado

Gold Breaks a 3-Day Win Streak -- Market Talk

14 jul 2025, 18:59 UTC

Charlas de Mercado

Hotter Weather Outlook, LNG Flows Boost U.S. Natural Gas -- Market Talk

14 jul 2025, 18:30 UTC

Adquisiciones, fusiones, absorciones

Synopsys Buy of Ansys Gets China OK. The $35 Billion Deal Is Set to Close. -- Barrons.com

14 jul 2025, 18:25 UTC

Charlas de Mercado

Dollar Gains, Treasury Yields Lose Steam as Trump Threatens Russia -- Market Talk

14 jul 2025, 18:25 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

14 jul 2025, 16:59 UTC

Charlas de Mercado

Goldman Sachs Lifts 2H25 Crude Price Views -- Market Talk

14 jul 2025, 16:53 UTC

Acciones populares

Stocks to Watch Monday: Kenvue, Tesla, Synopsys, Robinhood -- WSJ

14 jul 2025, 16:27 UTC

Charlas de Mercado

Oil Falls as Investors Monitor U.S.-EU Trade, Trump's Russia Sanction Threats -- Market Talk

14 jul 2025, 16:20 UTC

Charlas de Mercado
Ganancias

Auto & Transport Roundup: Market Talk

14 jul 2025, 16:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

14 jul 2025, 16:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

14 jul 2025, 16:12 UTC

Charlas de Mercado
Adquisiciones, fusiones, absorciones

Waters Closer to Thermo Fisher, Danaher With Becton Dickinson Unit -- Market Talk

Comparación entre iguales

Cambio de precio

IQVIA Holdings Inc previsión

Precio Objetivo

By TipRanks

8.91% repunte

Estimación a 12 Meses

Media 177.31 USD  8.91%

Máximo 211 USD

Mínimo 159 USD

De acuerdo con 15 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para IQVIA Holdings Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

15 ratings

11

Comprar

4

Mantener

0

Vender

Puntuación técnica

By Trading Central

150.68 / 153.45Soporte y Resistencia

Corto Plazo

Bullish Evidence

Medio plazo

Neutral Evidence

Largo Plazo

Bearish Evidence

Sentimiento

By Acuity

21 / 376 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista notoria

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por encima de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de IQVIA Holdings Inc

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE; and a strategic collaboration with NVIDIA Corporation. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.